JOSEPH CIPRIANO: Open Payments
NPI 1922558683 · VINELAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,155 in 51 payments from 8 companies in 2025. Trend: 2023 $897 · 2024 $1,197 · 2025 $1,155
Food & beverage: $1,155
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 35 | $859 |
| Gilead Sciences, Inc. | 6 | $114 |
| ABBVIE INC. | 5 | $85 |
| Exact Sciences Corporation | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: CABENUVA, RUKOBIA, APRETUDE, DOVATO, MAVYRET, VRAYLAR, Cologuard Collection Kit, Yeztugo.
Industry payments across NJ — which companies pay providers there.
